Senior Scientist - Analytical Development, Protein Sciences
Listed on 2026-10-16
-
Research/Development
Research Scientist, Pharmaceutical Science/ Research, Biotech Research, Drug Discovery
T-Therapeutics is a next-generation T cell receptor (TCR) company spun out from the University of Cambridge. The company was created to harness the power of T cell biology, to create safe and effective treatments for cancer and autoimmune disease. T-Therapeutics’ experienced team combines world-leading expertise in mouse genome engineering, single cell genomics, biopharmaceutical drug development, machine-learning and structural biology, anchored in a culture of creativity and collaboration.
T-Therapeutics is developing ‘optimal’ TCR therapeutics using its proprietary Op Ti Mus ® discovery platform, that provides an almost unlimited source of unique, antigen‑specific human TCRs. The company is developing a pipeline of first‑in‑class drugs that are intended to become transformative medicines, reshaping the clinical landscape for patients with cancer or autoimmune diseases.
We are seeking an experienced, highly motivated Senior Scientist – Analytical Development to join our Protein Sciences Team. The ideal candidate will bring extensive expertise in Mass Spectrometry (LC‑MS/MS) for protein characterisation and a strong background in developing and implementing analytical methods to support the advancement of pre‑clinical biologics programmes.
This role will lead the development of mass spectrometry‑based methods and as well as other characterisation assays for biologics, while also overseeing outsourced methods development and phase appropriate validation to support regulatory submissions.
In this role you will be responsible for:- Development, optimisation and troubleshooting of analytical methods focused on mass spectrometry for protein characterisation (including intact mass analysis, peptide mapping and glycosylation analysis).
- Development and optimisation of HPLC/UPLC
-based methods, including HIC, HILIC, SEC and reverse‑phase chromatography
. - Leading develop ability and characterisation studies to support pre‑clinical and early development programmes.
- Providing technical oversight of development and validation of outsourced analytical methods in support of future IND/BLA submissions.
- Interpretation, documenting, and presenting data and findings to cross‑functional teams and stakeholders.
- Collaborating within CMC and across multiple teams within the company.
- Mentoring to junior colleagues and encouraging development of additional Mass Spectrometry users or system owners.
- imateelf degree (PhD with industry experience) in analytical chemistry, biochemistry or a related field is desired.
- Hands‑on experiencelern with mass spectrometry (e.g. LC‑MS, QTOF, Orbitrap) and HPLC/UPLC techniques.
- Strong experience with a range of analytical methods for protein characterisation such as liquid chromatography (e.g. RP, SEC, HIC), capillary electrophoresis would be an advantage.
- Proficiency in data analysis software (e.g. Mass Lynx, Waters connect, Empower).
- Proven record of leading method development is essential.
- Experience in characterisation of complex biologics is essential.
- Deep understanding of ICH guidelines and experience with IND/BLA submissions would be an advantage. ręmy>
- Strong analytical and problem‑solving skills.
Ability to work independently and as part of a team.
Referrals increase your chances of interviewing at T-Therapeutics Ltd by 2x.
(If this job is in fact in your jurisdiction, then you may be using a Proxy or VPN to access this site, and to progress further, you should change your connectivity to another mobile device or PC).